203 related articles for article (PubMed ID: 12666074)
1. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.
Eknoyan G; Latos DL; Lindberg J;
Am J Kidney Dis; 2003 Apr; 41(4):868-76. PubMed ID: 12666074
[TBL] [Abstract][Full Text] [Related]
2. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine treatment of anemia.
Golper TA; Goral S; Becker BN; Langman CB
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S27-34. PubMed ID: 12751051
[TBL] [Abstract][Full Text] [Related]
4. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
Steinman TI
Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
[TBL] [Abstract][Full Text] [Related]
5. [Anemia in chronic renal failure. The role of L-carnitine in the treatment of anemia of hemodialyzed patients].
Wanic-Kossowska M; Kurzawska-Firlej D; Kaźmierski M; Czekalski S
Pol Arch Med Wewn; 2003 Jan; 109(1):105-11. PubMed ID: 12879773
[No Abstract] [Full Text] [Related]
6. Levocarnitine and dialysis: a review.
Schreiber B
Nutr Clin Pract; 2005 Apr; 20(2):218-43. PubMed ID: 16207659
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine supplementation in dialysis: treatment in quest of disease.
Wasserstein AG
Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
[TBL] [Abstract][Full Text] [Related]
8. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
Boran M; Dalva I; Gönenç F; Cetin S
Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
[No Abstract] [Full Text] [Related]
9. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
10. Use of Carnitor for Epogen resistant anemia.
Simard JC
ANNA J; 1999 Feb; 26(1):41-2. PubMed ID: 10222857
[TBL] [Abstract][Full Text] [Related]
11. Dialysis-related carnitine disorder and levocarnitine pharmacology.
Evans A
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
[TBL] [Abstract][Full Text] [Related]
12. Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients.
Higuchi T
Contrib Nephrol; 2018; 196():96-100. PubMed ID: 30041211
[TBL] [Abstract][Full Text] [Related]
13. L-carnitine and erythropoietin requirements in hemodialysis patients.
Kavadias D; Fourtounas C; Tsouchnikas J; Barboutis K
Am J Kidney Dis; 1996 Jul; 28(1):156. PubMed ID: 8712214
[No Abstract] [Full Text] [Related]
14. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine in dialysed patients: the choice of dosage regimen.
Berard E; Iordache A; Barrillon D; Bayle J
Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
[No Abstract] [Full Text] [Related]
17. History of L-carnitine: implications for renal disease.
Matera M; Bellinghieri G; Costantino G; Santoro D; Calvani M; Savica V
J Ren Nutr; 2003 Jan; 13(1):2-14. PubMed ID: 12563618
[TBL] [Abstract][Full Text] [Related]
18. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
[No Abstract] [Full Text] [Related]
19. The role of carnitine in maintenance dialysis therapy.
Morgans HA; Chadha V; Warady BA
Pediatr Nephrol; 2021 Aug; 36(8):2545-2551. PubMed ID: 34143302
[TBL] [Abstract][Full Text] [Related]
20. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
